With respect to microbiota composition, the relative abundance of Akkermansia muciniphila appears to significantly affect the clinical response to anti-PD-1/PD-L1 therapy in NSCLC and renal cell carcinoma. This evidence concerns the gene CD274 and non-small cell lung carcinoma.